MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity

Stindt, M.H., Carter, S., Vigneron, A.M., Ryan, K.M. and Vousden, K.H. (2011) MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity. Cell Cycle, 10(18), pp. 3176-3188. (doi: 10.4161/cc.10.18.17436)

Abstract

The tumor suppressor p53 is extensively regulated by post-translational modification, including modification by the small ubiquitin-related modifier SUMO. We show here that MDM2, previously shown to promote ubiquitin, Nedd8 and SUMO-1 modification of p53, can also enhance conjugation of endogenous SUMO-2/3 to p53. SUMOylation activity requires p53-MDM2 binding but does not depend on an intact RING finger. Both ARF and L11 can promote SUMO-2/3 conjugation of p53. However, unlike the previously described SUMO-1 conjugation of p53 by an MDM2-ARF complex, this activity does not depend on the ability of MDM2 to relocalize to the nucleolus. Interestingly, the SUMO consensus is not conserved in mouse p53, which is therefore not modified by SUMO-2/3. Finally, we show that conjugation of SUMO-2/3 to p53 correlates with a reduction of both activation and repression of a subset of p53 target genes

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Ryan, Professor Kevin and Carter, Dr Stephanie and Vigneron, Dr Arnaud and Vousden, Karen
• Authors: Stindt, M.H., Carter, S., Vigneron, A.M., Ryan, K.M., and Vousden, K.H.
• College/School: College of Medical Veterinary and Life Sciences > School of Cancer Sciences
• Journal Name: Cell Cycle
• ISSN: 1538-4101